The United States represents the largest share of the Albumin and Creatinine Tests Market in North America, driven by the high prevalence of chronic kidney disease (CKD), diabetes, and hypertension. According to healthcare statistics, millions of Americans are at risk of kidney-related complications, creating a strong demand for routine kidney function testing. The country's advanced healthcare...